Business Wire

Tris Pharma Receives U.S. FDA Approval for Once-Daily ONYDA XR (clonidine hydrochloride) Extended-Release Oral Suspension, the First-and-Only Liquid Non-Stimulant ADHD Medication

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Monthly Prescribing Reference

Onyda XR, a Nonstimulant Liquid ADHD Medication, Now Available

Credit: Tris Pharma Onyda XR is supplied as an orange-flavored oral suspension containing clonidine hydrochloride 0.1mg per mL. Onyda XR is the first nonstimulant liquid ADHD medication with nighttime ...
Medical Xpress

Studies find time-release medication keeps adults with ADHD on track, lowers substance use risk

They had higher rates of outpatient and emergency room visits, hospital stays and home health services compared to those who took extended-release versions and kept up with their medication schedule. ...
Healio

FDA approves Onyda XR extended-release liquid nonstimulant ADHD drug

Please provide your email address to receive an email when new articles are posted on . The FDA approved the treatment for patients with ADHD aged 6 years and older. Onyda XR is the first and only ...
MarketWatch

New Data Confirms Bioequivalence of Relexxii(R) and Concerta(R) in Healthy Adults(1)

The MarketWatch News Department was not involved in the creation of this content. ALPHARETTA, Ga., Aug. 19, 2025 /PRNewswire/ -- Alora Pharmaceuticals, LLC, the parent company of Vertical ...
Business Wire

Neos Therapeutics Resubmits New Drug Application for FDA Review of Amphetamine Extended-Release Orally Disintegrating Tablets to Treat ADHD

DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (NASDAQ: NEOS), a pharmaceutical company with a late‐stage pipeline of innovative extended-release (“XR”) product candidates for ...
Medscape

New-Generation Long-Acting Stimulants for the Treatment of Attention-Deficit/Hyperactivity Disorder

termed "ascending dose," was specifically designed to avoid acute tolerance, which is believed to be the cause of the diminished effectiveness of intermediate-acting methylphenidate preparations ...
Psychology Today

Substituting ADHD Medications During the Stimulant Shortage

The stimulant shortage is continuing for the foreseeable future. Many people who are on ADHD stimulant medications are still having a hard time finding them. Whether you can find a medication is ...